Invention Grant
- Patent Title: Aryl ureas as kinase inhibitors
- Patent Title (中): 芳基脲作为激酶抑制剂
-
Application No.: US10361859Application Date: 2003-02-11
-
Publication No.: US08110587B2Publication Date: 2012-02-07
- Inventor: Jacques Dumas , William J. Scott , Bernd Riedl , Du-Schieng Chien , Ala Nassar , Wendy Lee , Susan Bjorge , Laszlo Musza
- Applicant: Jacques Dumas , William J. Scott , Bernd Riedl , Du-Schieng Chien , Ala Nassar , Wendy Lee , Susan Bjorge , Laszlo Musza
- Applicant Address: US NY Tarrytown
- Assignee: Bayer Healthcare LLC
- Current Assignee: Bayer Healthcare LLC
- Current Assignee Address: US NY Tarrytown
- Agency: Millen, White, Zelano & Branigan, P.C.
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D211/72 ; C07D211/92
Abstract:
This invention relates to new aryl ureas and methods for their synthesis. The inventive compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.
Public/Granted literature
- US20030216446A1 Aryl ureas as kinase inhibitors Public/Granted day:2003-11-20
Information query
